Introduction. Health state valuation is a key input in many economic evaluations that inform resource allocation across competing healthcare interventions. Empirical evidence has shown that, in preference elicitation surveys, respondents may value a health state differently if they are aware of the condition causing it ('labeling effects'). This study investigates the impact of including a multiple sclerosis (MS) label for valuation of MS health states. Methods. Health state values for MS were elicited using two internet-based surveys in representative samples of the UK population (n = 1702; n = 1788). In one survey respondents were not informed that health states were caused by MS. The second survey included a condition label for MS. Surveys were identical in all other ways. Health states were described using a MS-specific eightdimensional classification system (MSIS-8D), and the time trade-off valuation technique was used. Differences between values for labeled and unlabeled states were assessed using descriptive statistics and multivariate regression methods. Results. Adding a MS condition label had a statistically significant effect on mean health state values, resulting in lower values for labeled MS states v. unlabeled states. The data suggest that the MS label had a more significant effect on values for less severe states, and no significant effect on values for the most severe states. The inclusion of the MS label had a differential impact across the dimensions of the MSIS-8D. Across the MSIS-8D, predicted values ranged from 0.079 to 0.883 for unlabeled states, and 0.066 to 0.861 for labeled states. Conclusion. Differences reported in health state values, using labeled and unlabeled states, demonstrate that condition labels affect the results of valuation studies, and can have important implications in decision-analytic modelling and in economic evaluations. Key words: QALY; labeling; preferences; preference-based measures; valuation; multiple sclerosis. (Med Decis Making 2017;37:703-714) E conomic evaluations in the healthcare setting commonly employ quality-adjusted life-years (QALYs) within cost-utility analyses to inform decisions on the reimbursement of healthcare interventions. The basic QALY construct is that individuals experience different health states over time and that each health state has a value attached to it, with QALYs used to represent the value-weighted (quality-adjusted) accumulated time; e.g., lifeyears. 1 Health state values (HSVs) are on a scale where the value of being dead is zero, and the upper end of the scale has a value of one, reflecting the best imaginable health state (or perfect health, or similar description). States worse than dead are possible, and have a negative value. HSVs reflect the relative preferences of respondents across different health states, whereby a health state description that is more (or less) desirable than others will have a value that is closer to (or further away from) the value of 1 than the comparison health states.
Although the use of the QALY in the assessment of health benefits in economic evaluations continues to be a major source of contention, 1,2 the QALY is widely used and is the recommended outcome measure in a number of policy settings. [3] [4] [5] [6] There are variations in the estimation of health state values and the major areas of uncertainty can be characterized into 3 broad methodological areas: what to value (i.e., how to describe health states), how to elicit preferences (how to value), and from whom to elicit preferences (whose values). Here, we are concerned with the first of these areas, considering whether to name the disease or health condition in the health state description being valued.
Empirical evidence suggests that values for the same health states can vary depending on whether the underlying condition is 'labeled' or not; i.e., made known to respondents. 7 Although some studies provide evidence that including labels for particular conditions significantly reduces HSVs, others have found no effect, and the results vary between conditions. [7] [8] [9] [10] [11] In a recent study, 7 the use of a label for cancer health states, compared to otherwise identical unlabeled health states, resulted in significantly lower HSVs for severe health states but did not affect valuations of milder states. There are alternative normative arguments for and against the use of condition labels. For example, the condition itself may have an affect on HRQoL that is unrelated to a generic health state description. Brazier and colleagues 12 have drawn attention to potentially different valuations when people have 'some difficulty in taking a long walk' when it is due to needing to be near a toilet or owing to psychological problems, v. having 'some difficulty taking a long walk' due to physical problems. In this case, condition labels may result in more accurate HSVs. Alternatively, respondents may be influenced by their own knowledge, experience, or preconceptions about the condition, in which case it may be argued that HSVs could be distorted due to irrelevant or inaccurate factors. However, there is little empirical evidence to explain such differences in the values ascribed to labeled and unlabeled health states, and a consensus has yet to be reached on the extent of the influence of condition labels on HSVs.
Several condition-specific, preference-based measures (CSPBMs) have been developed 13 for use as alternatives, or additions, to generic PBMs (e.g., EQ-5D, 14 and SF-6D
15
). Yet, even when using a CSPBM, the current guidelines suggests that, until more is known about which condition labels affect the HSVs and why discrepancies occur, the condition label should be avoided. 12 Given the apparent variability of labeling effects between conditions, further research has been recommended to investigate the impact of labels in studies valuing states for particular conditions. 7, 12 In this study, the development of a conditionspecific PBM for multiple sclerosis (MS) provided an opportunity to investigate the impact of including a condition label on public valuations of health states for MS, a chronic condition with a wide variety of symptoms. As far as we are aware, this study is the first to derive a full tariff of values for labeled and unlabeled versions of the same classification system.
METHODS
Two surveys were undertaken to elicit preferences for MS health state descriptions. One avoided any mention of MS (the unlabeled version of the survey, Survey 1), while the other explicitly stated that the health states described the impact of MS (the labeled version, Survey 2). To ensure that the results of the 2 surveys were comparable, the same preference elicitation methods were used for both surveys, and the same approach was used for descriptive statistics and statistical analyses, consistent with current methodological guidance. 16 The MS health states were described using the Multiple Sclerosis Impact Scale Eight Dimension (MSIS-8D) classification system, 17 ( Figure 1 ), which was derived from the MSIS-29 item patient reported outcome measure, a frequently used and wellvalidated measure of health-related quality of life (HRQoL) in MS. 18, 19 The development of the MSIS-8D classification system is described in detail elsewhere. 17 The measure comprises 8 dimensions of importance to the HRQoL of people with MS: physical functioning, mobility, social activities, daily activities, fatigue, cognitive function, emotional well-being, and depression. Each dimension is represented by one MSIS-29 item, and each item has 4 response levels: 1) not at all, 2) a little, 3) moderately and 4) extremely.
The survey methods are described in more detail elsewhere. 20 Briefly, a sample of 169 MSIS-8D health states was selected to reflect states that are likely to be experienced by people with MS at different levels of severity. These health states were allocated to 5 severity groups according to the sum of their levels across dimensions (see Appendix). Each respondent valued 1 set of 5 MSIS-8D health states, covering a range of condition severity; the survey design comprised 34 sets of 5 health states, plus the worst health state described by the MSIS-8D as (i.e. the pits state). Before preference elicitation, respondents completed the MSIS-8D for their own health, ranked 3 MSIS-8D health states, and completed a practice TTO task. Preferences were elicited using an internet version of the Measurement and Valuation of Health (MVH) variant of the time trade-off (TTO) technique, 21 which asks respondents to state whether they would prefer 10 years in the target health state or a shorter period of time (x) in perfect health. The length of time spent in perfect health (x) is varied until the respondent is indifferent between the 2 options, and the HSV is calculated as x/10. Cognitive testing and an online pilot study (n = 50) were used before the full survey to ensure the online survey worked as intended. The MVH protocol for health state valuation, and the elicitation of preferences from a representative sample of the UK population were applied here to be consistent with recommendations from the UK National Institute for Health and Care Excellence (NICE) on methods for economic evaluations. 3 The online surveys were programmed and hosted by Accent Marketing and Research Ltd (http:// www.accent-mr.com/), with participants recruited from an existing internet panel held by Survey Sampling International (SSI), an experienced online panel provider with rigorous quality control procedures. Each survey aimed to obtain data from 1,700 respondents to achieve 40 to 50 observations per health state. Given an absence of guidance on sample size requirements for such studies, reference to the literature in this area indicated this target sample size was appropriate. To ensure that the sample was representative of the UK general population, rigid minimum quotas were set for age group (in 10-year age bands), gender, and socio-economic groups. Ethical approval for both surveys was obtained from the University of Exeter Medical School Research Ethics Committee.
The labeling of MS health states (Survey 2) was informed by the approach taken in a similar previous study. 7 The condition was mentioned in the introduction to the survey and in the health state descriptions that were used in the valuation tasks. Respondents were provided with information about the condition, based on the definition provided on the UK NHS Choices website ( Figure 2) 22 before completing the TTO questions. A link to the MS pages of the NHS Choices website was also included. Those who responded to the labeled version of the survey were asked which, if any, sources of information about MS they used to assist them in completing the TTO tasks (used survey description, they already know about MS, looked up additional information). One of the dimensions of the MSIS-8D specifically referred to 'your MS'. To remove any mention of MS from the unlabeled version of the survey, the phrase 'your MS' was replaced with 'your health'. This amended wording was retained for the labeled version of the survey, but the description of the health state was preceded by the phrase 'Due to having MS'.
The procedure for valuing states considered worse than being dead was consistent with the MVH approach. Before analysis, a monotonic transformation was applied to transform negative values on a scale from 0 to 21.
14 Data was excluded from respondents who provided responses that appeared internally inconsistent or illogical, specifically those where respondents: 1) Gave the same value to all 6 health states (unless they valued all health states as equivalent to full health), 2) Gave all states a value less than or equal to zero, 3) Valued the pits state at least as highly as all other states, 4) Gave the least severe state a lower value than all other states, or 5) Provided 3 or more inconsistent responses with a difference in HSV of at least 0.1; i.e., they valued a dominated health state as better than a logically better alternative by the equivalent of 1 year in the TTO exercise.
Analysis of the impact of adding an MS label to MSIS-8D health states was undertaken in 2 phases. In the first phase, mean HSVs from the labeled and unlabeled versions of the MSIS-8D valuation survey were compared using 2-sided t-tests, and comparisons made by severity group. In addition, data from both surveys were combined into a single dataset and a regression model was estimated using the following specification: 7 y ij 5a1f (b9X lq )1gq i 1e ij ; where i = 1, 2, . . ., n describes the individual health states; j = 1, 2, . . ., m is the individual respondents; y ij is the health state i valued by respondent j; X is the vector of dummy variables for each level l of dimension q of the classification system, where level l = 1 acts as a baseline for each dimension; q is the dummy variable for labelling effects, and e ij is the error term. This model, using random effects and a generalized least-squares structure to allow for multiple observations per respondent, 23 aims to determine whether inclusion of an MS label influenced HSVs when these were modeled using dimension-levels for each health state description. Model performance was assessed using root mean-squared error, R-squared statistics, and the Wald Chi-squared test. 7 In the second phase of the analysis, random effects models were estimated to produce a full tariff of the HSVs for the MSIS-8D descriptive system (i.e., CSPBM) from each version of the survey, as follows: 12 y ij 5f (b9X lq )1e ij
To ensure comparability between the models, the same model specification was used for both labeled and unlabeled data. 16 Where a lower level of severity resulted in a greater decrement (higher negative coefficient) to the HSV than a higher level of severity, levels were merged and the analysis was re-run to ensure a consistent model. 24 Models were compared in terms of their performance and predictive ability, using the following criteria: 1) the proportion of coefficients that are statistically significant; 2) the number of coefficients that are not consistent with the dimension levels; 3) mean absolute error (MAE); 4) the proportion of health states with prediction errors .0.05 and .0.10; 5) the R-squared statistics.
The size and significance of coefficients was compared to investigate differences in the weighting of individual dimensions and in the effect of moving between dimension-levels, and the ranges of HSVs predicted by the models were compared. To simplify the comparison between the coefficients of the 2 models, a rule was applied such that any absolute difference less than 0.01 would be considered negligible.
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RESULTS
The unlabeled survey (Survey 1) was completed by 1,702 respondents, and 1,788 completed the labeled survey (Survey 2). A slightly higher percentage of respondents were excluded from the labeled survey (8.2%) compared with the unlabeled survey (7.4%) due to inconsistent or illogical responses. Most of the exclusions (.75%) were due to respondents valuing the pits (worst) state at least as highly as all other states. Data from 1,576 respondents to the unlabeled survey and 1,641 respondents to the labeled survey were included in the final analysis. The median number of observations per health state was 47 for the unlabeled survey and 49 for the labeled survey. Table 1 reports the demographic characteristics of the participants compared with the total UK population. Overall, the samples were reasonably representative of the UK population. Although the percentage of participants aged over 65 years was similar to the general population, both samples included a higher proportion of respondents in the 66-to 75-year age band, and fewer respondents aged over 75 years. A lower proportion of respondents were in employment and a lower number had no qualifications as compared with the general population. There were no differences in the socio-demographic profiles of the 2 samples.
The mean directly elicited values for each health state in the unlabeled survey ranged from 0.08 for the pits state to 0.89 for the best health state described by the MSIS-8D, and from 0.07 to 0.89 for the labeled survey (see Appendix 1). Table 2 reports data on the ease or difficulty in making choices and on the understanding of the TTO questions. There was little difference between the labeled and unlabeled versions of the survey. Most respondents (81.4%) reported that they used the description of MS that was provided in the survey. Around onethird (34.7%) reported that they ''already knew quite a bit about MS''. Only 6.1% reported that they had looked up additional information about MS. Completion times were similar across surveys with a mean completion time of 10 min, 25 s (SD 8 min, 44 s). Table 3 reports the comparison of mean HSVs, showing a significant difference in overall mean HSVs between the labeled and unlabeled versions of the survey. The mean HSV was 0.023 lower when the MS label was included in the health state descriptions. The mean HSVs for the severity groups reflect the expected direction of preferences, with HSVs decreasing as severity increases. The difference in means was statistically significant (P \ 0.05) for 2 severity groups: the mildest group (Group 1) and one of the moderate groups (Group 4). At the 10% level, the difference between means was significant for the 4 mildest severity groups. The differences between the means for the most severe group (Group 5) and for the pits state were not statistically significant. The results of the model estimated using data from both samples are presented in Table 4 . These results broadly reflect the expected direction of preferences, with mean HSVs decreasing as severity increases. The impact of the condition label is statistically significant, with a negative coefficient, indicating that the presence of an MS label lowers mean HSVs. The P value for the Wald Chi-squared test was \0.001. Table 5 reports the sets of full CSPBM tariffs, across all described health states, estimated from the labeled and unlabeled datasets (i.e. MSIS-8D-unlabeled, and MSIS-8D-labeled). The coefficients of both models had the expected negative sign; i.e., as impairments in health status worsened for each dimension, it had a negative effect on HSVs. All model coefficients for the unlabeled version of the survey were consistent with the expected preferences, coefficients increasing as the level of impairment increased, with lower HSVs for increased impairment on that dimension. In the initial random effects model for the labeled version of the survey, 3 coefficients were inconsistent with the expected direction of preference. Therefore, levels were merged to create a consistent model, which was re-estimated using data from the labeled version of the survey by merging levels 2 and 3 for the physical, social and emotion domains.
The predicted HSVs ranged from 0.079 to 0.883 for the unlabeled version of the survey and from 0.066 to 0.861 for the labeled version. The differences between the coefficients of the 2 models are illustrated in Figure 3 .
The addition of the MS label resulted in an increase in absolute coefficient sizes for 5 of the MSIS-8D dimensions: an increase in coefficient size indicates that moving from level 1 to the level corresponding to the coefficient has a greater negative impact on HSVs. These were: physical (coefficients for levels 2 and 3), social (levels 2 and 4), mobility (all levels), fatigue (level 3), and cognition (levels 3 and 4). The labeled version had a higher number of significant coefficients for the mobility, fatigue and cognition dimensions.
The addition of the MS label resulted in a reduction in absolute coefficient sizes for the remaining 3 dimensions: a decrease in coefficient size indicates that moving from level 1 to the level corresponding to the coefficient has a smaller negative impact on HSVs. These were: daily activities (all levels), emotion (levels 3 and 4), and depression (levels 2 and 4). Table 5 also reports the effect of including an MS label on the distance between adjacent coefficients, reflecting the impact of moving between levels on each dimension of the MSIS-8D, using the aforementioned rule (on differences .0.01). This suggests a more complex scenario than was apparent from the overall effects on coefficient sizes. For example, if we move from level 1 to level 2 on the physical dimension, this has a larger impact on HSVs when modeled using labeled data, but moving from level 3 to level 4 on the same dimension has a larger impact when modeled using the unlabeled data. Indeed, 4 of the 8 MSIS-8D dimensions have a mix of larger and smaller single-level increments when the 2 models are compared (physical, social, fatigue, depression).
When the condition was labeled, more of the dimension coefficients were significant (n = 14), compared with the model for the unlabeled data (n = 11). Conversely, inclusion of the MS label was detrimental to the performance and predictive ability of the estimated model, reducing the size of the within and overall R-squared statistics, slightly increasing the MAE and RMSE, and producing more health states with prediction errors greater than 0.1 or 0.05. There was no difference between the Wald chi-squared P values of the models.
DISCUSSION
The results of the current study indicate that adding an MS label to descriptions of health states significantly reduces the estimated overall mean health state values as compared with the values elicited for otherwise identical unlabeled states. Data from directly elicited HSVs suggests that the MS label had a more significant effect on values for less severe health states and no significant effect on values for the most severe states, reflecting a reversal of the findings reported by Rowen and others, 7 who found that including a cancer label had a more significant impact on severe states.
However, this overall finding masks a more complex underlying pattern in the data, as the inclusion of the MS label had a differential impact across the dimensions of the MSIS-8D. For mental health dimensions (depression and emotional well-being) and for daily activities, the impact of the condition label was to reduce the impact of impairments (increasing severity) on the HSVs; i.e., smaller decrements in the HSV when an impairment was present as compared with the unlabeled data. On the contrary, the impact of the condition label on estimated HSVs of limitations in physical health dimensions (physical and mobility), social activities, fatigue and cognition was increased; i.e., greater decrements in the HSV when an impairment was present as compared with unlabeled data. These findings suggest interventions that target physical symptoms, social activities, fatigue and cognition may appear more effective (greater health gain if symptoms alleviated), and hence more costeffective, if assessed using the labeled version of the MSIS-8D model, whereas interventions that improve mental and emotional wellbeing may appear less effective and cost-effective as compared with an assessment with unlabeled data.
An added level of complexity is introduced by the differences between the models in terms of the impact on HSVs of moving between individual levels within each dimension. Furthermore, the model based on the labeled health state data was more sensitive to changes in moderate levels of some domains, with more significant coefficients at level 2 (mobility) and level 3 (mobility, fatigue and cognition).
Our findings suggest that the inclusion of a condition label when estimating HSVs may have important implications for the results of economic evaluations. In a decision-analytic context, it is the difference (interval) between health state values (e.g., pre-and post-intervention) that are most relevant rather than absolute HSVs. For example, if all labeled health states were valued 0.02 higher than all unlabeled health states, both sets of HSV data should produce identical values for any given change in health status and there would be no difference in the results of economic evaluations (assuming no impacts from mortality effects). It is the difference in the relative weighting of dimensions and in the effect of changes in individual dimension levels that is relevant in determining the effects of condition labels on the results of cost effectiveness analysis. To illustrate, a shift from health state 22323222 (level 3 on the mobility and fatigue dimensions, level 2 on all other dimensions) There was little difference in the performance or predictive ability of the 2 models. The model based on labeled data had slightly lower predictive ability in terms of the R-squared statistics, MAE, RMSE, and the number of health states with prediction errors greater than 0.1 or 0.05. This may be due to the increased cognitive demand placed on respondents to the labeled version of the study, who were asked to imagine that they had MS in addition to imagining themselves in the health states described.
There were several limitations with the study. In keeping with previous guidance, 3 valuation methods were consistent with the MVH version of the TTO protocol. One consequence of this is that the protocol asks respondents to imagine remaining in a specified health state for 10 years, with no changes in that health state during that time. However, the definition of MS that was provided for respondents to the labeled version of the survey stated that MS is usually characterized by alternating periods of relapse and remission, or by ongoing progression. This may have caused confusion for respondents to the labeled version of the survey and may have affected the values they attributed to health states. This is a potential area for further research.
Concerns have been raised about whether TTO tasks may pose too high a cognitive burden for online administration. 25 Although recent evaluations of internet TTO have produced mixed results, [26] [27] [28] the nature of the preference data elicited here, alongside respondents' self-reported task comprehension, suggests that the TTO technique can be administered successfully online.
A central limitation of this study is that it is quantitative in nature and therefore cannot explain why HSVs differ between labeled and unlabeled health states. The reasons for the differences in the health state values require investigation using qualitative methods. There are several possible mechanisms that may explain the differences between values elicited for labeled and unlabeled health states. It may be that differences arise due to a legitimate effect of the condition per se; for example, contextual effects that provide differing explanations for impairments in functioning. Alternatively, labeling health states may prompt respondents to take irrelevant or inaccurate factors into account, or lead to 'focusing effects', thereby distorting HSVs. Use of a condition label may lead to respondents own preconceptions about the condition being overly prominent, 29 and/or to increased influence of social attitudes, 24 and/or to poor hedonic forecasting. Further research in this area is planned to explore how and why respondents' cognitive processes differ when undertaking TTO tasks for labeled and unlabeled MSIS-8D health states. This will also enable an investigation of the suitability of the 10-year time-frame for a variable, progressive condition, as mentioned above.
30
To our knowledge, this is the first study to undertake 2 full-scale preference elicitation surveys for the same condition-specific classification system, using large, representative samples of the general population and a large sample of health states, to compare both observed and predicted values for labeled and unlabeled health states. The results Note: Diff, difference; +, indicates that MS label increased the size of the coefficient or the impact of moving between levels; 2, indicates that MS label reduced the size of the coefficient or the impact of moving between levels. *P \ 0.05; **P \ 0.01. Levels 2 and 3 were merged in the labelled version for Physical, Social and Emotion.
presented and discussed here show that including an MS label in health state descriptions reduces the overall estimated health state values associated with MSIS-8D health states and affects the relative importance of individual dimensions of HRQoL in influencing HSVs. The differences reported here between health state values by labeled versus unlabeled states could be considered relatively small, in a descriptive context. However, in economic evaluations, the mean HSVs and related QALY differences (between comparators) are often relatively small and we consider the findings here to be important, firstly in addressing an area of methodological uncertainty, but also for applied decision making contexts. We acknowledge that it will only be in the consideration of any differences (in HSVs) in a decision-analytic context (policy, CUA setting) that we may see the magnitude of the impact of using condition labels to elicit preferences and to estimate HSVs, and this is the focus for ongoing and future research.
